{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:28:35Z","timestamp":1793831315943,"version":"4.6.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jjcc.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T03:56:50Z","timestamp":1742270210000},"page":"127-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Milestones in therapeutic and antithrombotic strategies for chronic thromboembolic pulmonary hypertension"],"prefix":"10.1016","volume":"86","author":[{"given":"Kazuya","family":"Hosokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2025.03.006_bb0005","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2008.08.059","article-title":"Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan effects in iNopErable forms of chronIc thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial","volume":"52","author":"Jais","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0015","first-page":"239","article-title":"Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial","volume":"7","author":"Sadushi-Kolici","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0020","article-title":"Selexipag for the treatment of chronic thromboembolic pulmonary hypertension","volume":"60","author":"Ogo","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0025","first-page":"785","article-title":"Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study","volume":"5","author":"Ghofrani","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0030","article-title":"Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH).","volume":"9","author":"Escribano-Subias","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0035","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00193-2024","article-title":"Efficacy and safety of selexipag in patients with inoperable or persistent\/recurrent CTEPH (SELECT randomised trial).","volume":"64","author":"Kim","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072241","article-title":"Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA trial)","volume":"13","author":"Shimokawahara","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1378\/chest.64.1.29","article-title":"Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension","volume":"64","author":"Moser","year":"1973","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0050","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0055","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jtcvs.2018.04.110","article-title":"Residual pulmonary hypertension after pulmonary endarterectomy: a meta-analysis","volume":"156","author":"Hsieh","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.CIR.103.1.10","article-title":"Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension","volume":"103","author":"Feinstein","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0065","first-page":"748","article-title":"Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension","volume":"5","author":"Mizoguchi","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0070","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0075","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.124.068610","article-title":"Worldwide CTEPH registry: long-term outcomes with pulmonary endarterectomy, balloon pulmonary angioplasty, and medical therapy","volume":"150","author":"Delcroix","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0080","first-page":"949","article-title":"Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial","volume":"10","author":"Kawakami","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0085","first-page":"961","article-title":"Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study","volume":"10","author":"Jais","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0090","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacasi.2024.05.007","article-title":"Outcomes of chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty and pulmonary endarterectomy","volume":"4","author":"Masaki","year":"2024","journal-title":"JACC Asia"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0095","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.jtha.2023.03.036","article-title":"Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study","volume":"21","author":"Hosokawa","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.semtcvs.2006.09.008","article-title":"Outcomes of pulmonary endarterectomy surgery","volume":"18","author":"Thistlethwaite","year":"2006","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.athoracsur.2022.08.009","article-title":"Acute kidney injury after pulmonary thromboendarterectomy: associated factors and impact","volume":"117","author":"Wang","year":"2022","journal-title":"Ann Thorac Surg"},{"issue":"1519\u201328","key":"10.1016\/j.jjcc.2025.03.006_bb0110","article-title":"Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data","volume":"21","author":"Robin","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","article-title":"Extended use of dabigatran, warfarin, or placebo in venous thromboembolism","volume":"368","author":"Schulman","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0125","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0130","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0135","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.28033","article-title":"Clinical outcomes of direct oral anticoagulants vs warfarin for extended treatment of venous thromboembolism","volume":"6","author":"Fang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0140","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/jth.14649","article-title":"A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension","volume":"18","author":"Bunclark","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0145","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019873545","article-title":"Real-life data of direct anticoagulant use, bleeding risk and venous thromboembolism recurrence in chronic thromboembolic pulmonary hypertension patients: an observational retrospective study","volume":"10","author":"Sena","year":"2020","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0150","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.healun.2022.02.002","article-title":"Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension","volume":"41","author":"Humbert","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0155","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIRCULATIONAHA.123.067528","article-title":"A multicenter, single-blind, randomized, warfarin-controlled trial of edoxaban in patients with chronic thromboembolic pulmonary hypertension: KABUKI trial","volume":"149","author":"Hosokawa","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0160","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01294-2024","article-title":"Chronic thromboembolic pulmonary disease","volume":"64","author":"Kim","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0165","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220908","article-title":"Efficacy of dynamic chest radiography for chronic thromboembolic pulmonary hypertension","volume":"306","author":"Yamasaki","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.jjcc.2025.03.006_bb0170","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:16:31Z","timestamp":1785554191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508725000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0914508725000814"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.03.006","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Milestones in therapeutic and antithrombotic strategies for chronic thromboembolic pulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of Japanese College of Cardiology.","name":"copyright","label":"Copyright"}]}}